US FDA Commissioner Search: Did Sharpless’ Hopes Just Go Up In Smoke?
Executive Summary
US FDA Acting Commissioner Sharpless’ time in office may be rapidly running out. The Trump Administration appears ready to pick an outside candidate to run FDA, with MD Anderson’s Hahn now the apparent front-runner. A prominent Democratic Senator’s criticism of Sharpless and his response to vaping may be the final blow.
You may also be interested in...
MD Anderson Oncologist Stephen Hahn Is Trump’s First Choice For FDA Commissioner: Reports
Media reports say President Trump will nominate Stephen Hahn, an oncologist serving as chief medical executive of MD Anderson Cancer Center, as the next US FDA commissioner. This comes despite a group of former agency chiefs’ support for the current acting commissioner, Ned Sharpless, to permanently fill the spot.
US FDA Commissioner Transition: Sharpless Audition Is Ending – Will He Get The Part?
Ned Sharpless has been acting head of the US FDA for five months but has not yet been formally nominated for the permanent post. The emergence of another new name as a possible candidate underscores how uncertain the transition still is.
US FDA Alzheimer Guidance Update Reflects Changes In Biomarkers – And Leadership
Latest update to draft guidance on early Alzheimer’s drug development is the third iteration of a document first published in 2013. The history of the guidance is a reflection of structural and leadership changes in the neurology review team at FDA.